This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

IP licensing and business: Oct. 11-Oct. 23

By Nick Robertson ( October 23, 2025, 21:39 GMT | Insight) -- Western biopharma firms are looking to China for new treatments, with Roche, Gilead and AviadoBio each reaching licensing agreements for novel Chinese-developed therapies. Patent licensing news was led by pharmaceutical companies in recent weeks, with Roche, Gilead and AviadoBio each looking to China for novel therapies. LED lighting leaders Nichia and ams OSRAM also announced a broad cross-licensing agreement covering thousands of patents....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login